Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
Chinese goalkeeper Sui Weijie has been fined 50,000 yuan (£5,240) after allowing an opponent to score while he sipped on a bottle of water
A "caring and loving" teenage boy who "lit up the life" of everyone he met has died in hospital after taking what he thought was ecstasy.
Nicola Sturgeon has attacked the "scale and speed" of the Conservatives' planned spending cuts in her first major post-election speech.